Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Completed

CardioTek EP-TRACER Software V2.x.

FDA Recall Z-1283-2022 · Posted None

Recalling FirmCardioTek BV
Recall StatusCompleted
Product CodeDQK
Date Initiated2022-04-25
Product Quantity146 units

Reason for Recall

Device did not pass electrical safety testing for adequate insulation.

Firm Action

The firm issued a recall notification to consignees on 04/25/2022 via email. On 05/24/2022 the firm sent an updated field safety notice. The consignee can continue to use the device. The firm will contact the customer to schedule an appointment for the rework. The consignee is to pass on the letter to those that need to be made aware of the notice.

Root Cause

Under Investigation by firm

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the states of CA, NY, NC and the countries of South Korea, Mexico, Kazakhstan, Netherlands, Spain, Germany, Finland, Poland, Israel, Turkey, Chile, Ecuador, Austria, Croatia, Sweden, United Kingdom, Colombia, Italy, Portugal, Canada, Saudi Arabia, Belgium, Slovenia, Brazil, Hungary, Malaysia, Uzbekistan.

Related FDA 510(k) Records

Devices referenced by this recall via K-numbers.

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑